Loading...
XHKG
0853
Market cap2.65bUSD
Dec 05, Last price  
11.18HKD
1D
-0.71%
1Q
-20.77%
Jan 2017
91.44%
IPO
37.18%
Name

Microport Scientific Corp

Chart & Performance

D1W1MN
XHKG:0853 chart
P/E
P/S
2.57
EPS
Div Yield, %
Shrs. gr., 5y
1.81%
Rev. gr., 5y
5.38%
Revenues
1.03b
+8.45%
82,121,678109,718,029133,627,525149,149,365154,891,885355,284,000375,844,000389,921,000444,190,000669,490,000793,493,000648,732,000778,639,000840,831,000950,725,0001,031,063,000
Net income
-214m
L-55.19%
27,295,44136,200,02351,050,91456,711,11424,509,095-59,461,000-12,086,00014,141,00018,823,00023,913,00029,009,000-223,348,000-351,295,000-588,115,000-477,629,000-214,043,000
CFO
-50m
L-78.58%
29,718,40929,564,78747,753,38145,753,71559,001,62317,806,00030,720,00082,534,00097,186,00084,130,00026,451,000-23,200,000-257,530,000-343,303,000-231,873,000-49,669,000
Dividend
Jun 28, 20210.043 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.
IPO date
Sep 24, 2010
Employees
8,884
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT